Alcohol Use Disorder (AUD) Clinical Trial
Official title:
Pathological Risk: Dynamics of Risk Perception and Risk Behavior in Alcohol Use Disorder and Schizophrenia
The hyper- or hypo-attribution of risks is deeply related to the core pathological mechanisms of mental disorders and at the same time engaging in risky behaviors influences their course and outcomes. The investigators study risk perception, risk behaviors and underlying brain mechanisms in a longitudinal design in three groups of psychiatric patients who participate in a psychological intervention that is aimed to reduce risk behavior and increase risk perception. Patients with schizophrenia (SZ), alcohol use disorder (AUD) and both disorders (SZ + AUD) are recruited during psychiatric in-patient treatment and participate in a combined face-to-face and mobile intervention that starts before release and ends four weeks after discharge. The standardized 4-session face-to-face group intervention that is based on motivational interviewing (Miller & Rollnick, 2013) and relapse prevention (Marlatt & Donovan, 2005) and addresses the reduction of disorder-specific risk behaviors, i.e. alcohol use for AUD and SZ+AUD and medication non-adherence for SZ. After discharge, a 4-week ecological momentary intervention (EMI) supports participants to maintain abstinence from risk behaviors and to strengthen coping in high-risk situations relying on mental contrasting and implementation intentions (Oettingen & Gollwitzer, 2011). Participants will be assessed in fMRI and behavioral measurements and by self-report pre and post interventional phase, furthermore they participate in an ecological momentary assessment during the post-discharge phase which assesses risk behaviors, high-risk situations and risk perception in real life contexts.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT04927364 -
Examining the Effectiveness of Deep TMS in Veterans With Alcohol Use Disorder
|
N/A | |
Active, not recruiting |
NCT04618653 -
Comprehensive Process Model of AA-related Behavior Change
|
||
Recruiting |
NCT05471154 -
Non-invasive Brain Stimulation of the Prefrontal Cortex in Substance Use Disorders
|
N/A | |
Completed |
NCT05021640 -
Study of DCR-AUD in Healthy Volunteers
|
Phase 1 | |
Not yet recruiting |
NCT05064228 -
Mobile Rewarding Activity Centered Treatment
|
N/A | |
Completed |
NCT04958655 -
Mental Imagery Intervention for Alcohol Craving
|
N/A | |
Completed |
NCT05252221 -
Alcohol Telemedicine Consultation in Primary Care (ATC)
|
N/A | |
Completed |
NCT06108115 -
Smartphone-Based Intervention for Sleep Disturbance in Individuals Recovering From Alcohol Use Disorder
|
N/A | |
Not yet recruiting |
NCT06303778 -
Combining a Smartphone App With Medications to Manage Heavy Drinking
|
N/A | |
Completed |
NCT04639895 -
Cognitive Rehabilitation Through Personalized Virtual Reality and Paper-and-pencil Interventions in the Alcohol Use Disorder Treatment.
|
N/A | |
Completed |
NCT02911285 -
NAC for Treating Comorbid PTSD and SUD
|
Phase 2 | |
Recruiting |
NCT04598399 -
Comparison of the Effectiveness of Two Psycho-physical Interventions: Mindfulness Based Relapse Prevention (MBRP) and Unguided Meditative Relaxation in Patients With Alcohol Use Disorder
|
N/A | |
Completed |
NCT04827056 -
Effect of Sublingual Formulation of Dexmedetomidine HCl (BXCL501) - Alcohol Interaction Study
|
Phase 1 | |
Completed |
NCT04974645 -
Pilot: Digital Therapeutic vs Education for the Management of Problematic Substance Use
|
N/A | |
Recruiting |
NCT05992272 -
Cue Effects in Human Addiction: Pavlovian to Instrumental Transfer
|
||
Completed |
NCT04229095 -
Medication Development in Alcoholism: Suvorexant Versus Placebo
|
Phase 2 | |
Recruiting |
NCT05534568 -
The Oklahoma Parent-Child Assistance Program
|
N/A | |
Completed |
NCT04925570 -
The Anchor Study: Digitally Delivered Intervention for Reducing Problematic Substance Use
|
Phase 2 | |
Active, not recruiting |
NCT05492942 -
Records for Alcohol Care Enhancement
|
N/A | |
Recruiting |
NCT05015881 -
Relationship Between Brain and Heart Glucose Metabolism in Alcohol Use Disorder
|
Phase 2/Phase 3 |